RJS's post circa 2006 got me thinking about GNBT p
Post# of 36536
With the proposed dividend come Monday, I will have a number of shares of NGIO, which is likely to be listed on the NAS in the next 30 - 60 days.
If NGIO opens at $4 per share, I will have recouped 55% of ALL money I have invested in GNBT since 2006, when I first invested for Oralyn and the ii-key tech with bird flu. If the price rises to $6, the percentage I will have recouped rises to 80% of all money invested over the 14 years. If it rises to $10, I will have made 35% on all money that I've invested in GNBT since 2006. Not a great return for 14 years, but a return none the less.
But here's the IMPORTANT part...those calculations assume GNBT goes to $0 at the same time. This is almost an impossibility, since GNBT will own somewhere between 50 and 70% of NGIO, depending on how they allocate shares to finance other operations. Therefore, if I make the ultraconservative assumption that with NGIO trading at $4, GNBT will trade at $1, I now have recouped all money invested in GNBT over 14 years, and made an 5% profit on that money.
If NGIO is at $6 and GNBT is at $3, I will have made 100% on all money (a 5.1% annual return over 14 years).
At $10 for NGIO and $5 for GNBT, I will have made about 250% on the invested money, translating to an approximate 7% annual return for the 14 years. In reality, the return is actually much higher, since I had written off the money as a sunk cost 3 years ago.
Not bad for money that I thought 3 years ago was gone...forever. It still might be, considering that this could all fall apart in the next 30 - 60 days. But the odds of some portion of this succeeding vs it totally failing sure appear to be in our favor.
Back when the 1 for 1 dividend was announced in 2019, I stated that if we all wait until Thanksgiving, we will all know a lot more about GNBT and I thought we'd be very pleased with what we learned. Now with the 5 month dividend delay and terms modification, that date has been pushed back to around May 1. So I will restate my position - come Memorial Day, we will all know a lot more about this company and what it's true potential is. And I still am optimistic that it will be very good for investors, not to mention diabetes, wound care and cancer patients.